Search

everythinglearnresearchcommunity

for

Search:↓

3D-ultrasound can non-invasively detect and predict alopecia areata phases and outcomes.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Baricitinib improved hair loss and arthritis in a lupus patient.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

It's not possible to get unlimited hair for transplants from the same donor area.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

Jiawei Erzhiwan helps hair growth in androgenetic alopecia by affecting specific cell pathways.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

PINCH-1 is crucial for skin cell adhesion and movement, working with EPLIN and ILK.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

Baricitinib is effective and safe for treating severe alopecia areata.

Hair follicles are crucial for maintaining skin barrier function.

Alk1 in specific cells is crucial for proper nerve branching and hair function.

Baricitinib is effective and safe for treating severe alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Baricitinib may effectively treat oral lichen planus.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

A new gene mutation linked to a skin condition was found in a Spanish family.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

Ritlecitinib is safe and may effectively treat alopecia areata.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Hair evaluation is crucial for early diagnosis and management of ARCI, as hair loss often indicates severity.

The document concludes that automatic biofiber hair implant is a new method for improving hair growth.